A multicenter, randomized, open-label, controlled trial to evaluate the efficacy and tolerability of hydroxychloroquine and a retrospective study in adult patients with mild to moderate coronavirus disease 2019 (COVID-19).

Cheng-Pin ChenYi-Chun LinTsung-Chia ChenTing-Yu TsengHon-Lai WongCheng-Yu KuoWu-Pu LinSz-Rung HuangWei-Yao WangJia-Hung LiaoChung-Shin LiaoYuan-Pin HungTse-Hung LinTz-Yan ChangChin-Fu HsiaoYi-Wen HuangWei-Sheng ChungChien-Yu ChengShu-Hsing Chengnull null

Published in: PloS one (2020)

Neither study demonstrated that HCQ shortened viral shedding in mild to moderate COVID-19 subjects.

Keyphrases

coronavirus disease
open label
double blind
sars cov
phase iii
phase ii
clinical trial
phase ii study
study protocol
placebo controlled
respiratory syndrome coronavirus
locally advanced